Reuters logo
4 months ago
BRIEF-Clinigen and Onxeo initiate managed access programme for belinostat in Europe for patients with peripheral T-cell lymphoma (PTCL)
April 24, 2017 / 5:30 PM / 4 months ago

BRIEF-Clinigen and Onxeo initiate managed access programme for belinostat in Europe for patients with peripheral T-cell lymphoma (PTCL)

April 24 (Reuters) - Onxeo SA:

* Clinigen and co initiate managed access programme for belinostat in Europe for patients with peripheral T-cell lymphoma (PTCL) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below